|Bid||9.25 x 900|
|Ask||9.87 x 900|
|Day's range||9.50 - 9.89|
|52-week range||8.88 - 34.79|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||13 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||39.50|
Athira Pharma, Inc. (ATHA) closed at $10.13 in the latest trading session, marking a -1.65% move from the prior day.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
NEW YORK, August 24, 2021--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Athira Pharma, Inc. ("Athira " or "the Company") (NASDAQ: ATHA) on behalf of shareholders who purchased or otherwise acquired Athira common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company’s September 2020 initial public offering ("IPO